Archive for 2011

  • aside

    First patient enrolled in Isofol Medical’s initial trial with Modufolin® for treatment of neoadjuvant rectal cancer

    Isofol Medical AB today announced that the company has enrolled its first patient in the explorative phase I/II trial, LARS2,…

    by
  • aside

    Isofol Medical receives approval for Modufolin® manufacturing by the Swedish Medical Products Agency

    Isofol Medical AB today announced that the Swedish Medical Products Agency has approved the use of Isofol Medical’s newly produced…

    by